Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
Ito
N
N
Shimizu
Y
Y
Suzuki
H
H
Saito
T
T
Okamoto
T
T
Hori
M
M
Akahane
M
M
Fukumoto
S
S
Fujita
T
T
D000328:Adult; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001859:Bone Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000097:blood / Q000209:etiology*; D010257:Paraneoplastic Syndromes / Q000150:complications / Q000175:diagnosis*; D011446:Prospective Studies
D014408:Biomarkers, Tumor; C000717427:FGF23 protein, human; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23